Home › NCT07120763
Pain Control Alternatives in Pediatric Patients With Distal Radius Fractures
RecruitingPhase 3
Who can join
Ages 3 to 17 · All sexes
Full eligibility criteria
Inclusion Criteria: * Children requiring reduction for distal radius fracture * Children presenting to the emergency department * Children who are ages 3 to 17 years. Exclusion Criteria: * Pediatric patients \<3 years old * Adult patients (i.e. ages 18 or up) * Pediatric patients with injury patterns that are not amenable to hematoma block. * Children who are not a candidate for sedation related to BMI \> 95%tile for age, ASA class \> 2, Mallampati score \> 2, and pregnant patients
About the study
The aim of this study is to evaluate the efficacy of a hematoma block and minimal ketamine pain control or hematoma block and intranasal fentanyl in pediatric patients presenting with distal radius fractures requiring reduction, compared to control of standard full conscious sedation using ketamine.
What is being tested
- Ketamine + Lidocaine (drug)
- Ketamine group (drug)
- Fentanyl (Nasalfent, Fentanyl Citrate Nasal Spray) (drug)
Sponsor: State University of New York at Buffalo · Participants: 50 · Started: Aug 22, 2025
Contact the study team
- Dr. Ellen Lutnick Lutnick, MD · Phone: (716) 323-2100
Official record on ClinicalTrials.gov — NCT07120763
Locations in the U.S.
| New York | Oshei Children's Hospital, Buffalo |
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.